Lactulose and Pegintron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lactulose (lactulose) and Pegintron (peginterferon alfa-2b). Common drug interactions include haemoglobin decreased among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Lactulose and Pegintron. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.

What is Pegintron?

Pegintron has active ingredients of peginterferon alfa-2b. It is often used in hepatitis c. eHealthMe is studying from 10,326 Pegintron users. Check the latest studies of Pegintron.

On Aug, 02, 2026

29 people who take Lactulose and Pegintron together, and have interactions are studied.

Lactulose and Pegintron drug interactions.

What are the common drug interactions of Lactulose and Pegintron, by gender? *:

female:

Haemoglobin decreased
Pyrexia (fever)
Urinary tract infection
White blood cell count decreased
Blood bilirubin increased
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Platelet count decreased
Sepsis (a severe blood infection that can lead to organ failure and death)
Stomatitis (inflammation of mucous membrane of mouth)

male:

Weight decreased
Asthenia (weakness)
Hyperammonaemia
Infection reactivation
Intervertebral discitis (infection in the intervertebral disc space)
Diarrhoea
Headache (pain in head)
Infection
Mobility decreased (ability to move is reduced)
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Lactulose and Pegintron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Renal impairment (severely reduced kidney function)

50-59:

Headache (pain in head)
Pain
Pyrexia (fever)
Anaemia (lack of blood)
Back pain
Brain death
Chills (felling of cold)
Chronic kidney disease
Death
Flatulence (flatus expelled through the anus)

60+:

Haemoglobin decreased
Urinary tract infection
Asthenia (weakness)
Fatigue (feeling of tiredness)
Activities of daily living impaired
Anaemia (lack of blood)
Atelectasis (partial or complete collapse of the lung)
Blood glucose increased
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cough

What are the existing conditions these people have? *

Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 10.34%
Pain: 2 people, 6.90%
Itching: 2 people, 6.90%
Iron Deficiency Anaemia: 2 people, 6.90%
Insomnia (sleeplessness): 2 people, 6.90%
Hiv Infection: 2 people, 6.90%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.90%
Gastritis (inflammation of stomach): 2 people, 6.90%
Anaemia (lack of blood): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Lactulose and Pegintron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously